Advertisement
Home Tags Avastin

Tag: Avastin

The addition of bevacizumab to carboplatin/pemetrexed is associated with improved overall survival among patients with advanced non-small cell lung cancer

Adding Bevacizumab Improves Overall Survival in NSCLC

Addition of bevacizumab to carboplatin/pemetrexed beneficial in advanced non-small cell lung cancer
Seven or more injections of bevacizumab annually is associated with increased risk of glaucoma surgery

Glaucoma Surgery Risk Up With 7+ Injections of Bevacizumab

Patients who received four to six injections had a nonsignificantly increased risk of glaucoma surgery
A radiomic-based approach can be used to generate a prediction model for stratifying treatment outcome among patients with recurrent glioblastoma prior to bevacizumab treatment

Radiomic-Based Method Predicts Recurrent Glioblastoma Outcome

Radiomic-based superpc signature stratifies patients into low- or high-risk groups for PFS, OS
Compared with bevacizumab

Aflibercept, Ranibizumab Not Cost-Effective Vs. Bevacizumab

Not cost-effective for diabetic macular edema unless prices decrease considerably
Bevacizumab (Avastin) used to treat retinopathy of prematurity may be linked to serious disabilities such as cerebral palsy and hearing loss

Bevacizumab Use in Preemies Associated With Disabilities

Infants given the drug for retinopathy of prematurity more likely to have neurological complications
For patients undergoing cataract surgery

Bevacizumab, Triamcinolone Up Outcome After Cataract Surgery

Both linked to improvements in visual acuity; only triamcinolone tied to sustained improvement in CMT
Concerns that eye injections of the drug bevacizumab increase the risk of endophthalmitis may be unfounded

Study: No Higher Eye Infection Risk With Bevacizumab

Rates of endophthalmitis were 0.017 percent for bevacizumab and 0.025 percent for ranibizumab
An experimental vaccine and a drug already on the market each may help slow down advanced ovarian cancer

SGO: Promising Research in Treatment of Ovarian Cancer

Experimental vaccine and cancer drug each slow disease progression, researchers find